Olympus Corporation
OCPNFOTCHealthcare● Active
$11.18
+$0.00(+0.00%)
Market Cap$12.3B
P/E Ratio—
52W High$14
52W Low$8
Olympus Corporation (OCPNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OCPNF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
$0.14
Est. $0.05 · +193.5%
Revenue
$1.86B
Est. $1.78B · +4.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
OCPNF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | $0.06 | — | — | — | $1.41B | — |
| ▲ Q2 FY2026 | May 12, 2026 | $0.05 | $0.14 | +193.5% | $1.86B | $1.78B | +4.8% |
| ▼ Q1 FY2026 | Feb 13, 2026 | $0.15 | $0.08 | -44.2% | $1.67B | $1.66B | +0.2% |
| ▲ Q2 FY2025 | May 13, 2025 | $0.16 | $0.24 | +55.1% | $1.81B | $1.80B | +0.7% |
| ▼ Q1 FY2025 | Feb 14, 2025 | $0.22 | $0.15 | -31.2% | $1.60B | $1.59B | +0.5% |
| ▼ Q4 FY2024 | Nov 8, 2024 | $0.22 | $0.20 | -8.8% | $1.61B | $1.68B | -4.4% |
| ▼ Q3 FY2024 | Aug 7, 2024 | $0.09 | $0.08 | -13.9% | $1.46B | $1.44B | +1.3% |
| ▼ Q2 FY2024 | May 10, 2024 | $0.11 | $0.04 | -60.8% | $1.72B | $1.71B | +0.6% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
$0.14
EPS Est.
$0.05
EPS Surpr.
+193.5%
Revenue
$1.86B
Q1 FY2026
Feb 13, 2026Miss
EPS Actual
$0.08
EPS Est.
$0.15
EPS Surpr.
-44.2%
Revenue
$1.67B
Q2 FY2025
May 13, 2025Beat
EPS Actual
$0.24
EPS Est.
$0.16
EPS Surpr.
+55.1%
Revenue
$1.81B
Q1 FY2025
Feb 14, 2025Miss
EPS Actual
$0.15
EPS Est.
$0.22
EPS Surpr.
-31.2%
Revenue
$1.60B
Q4 FY2024
Nov 8, 2024Miss
EPS Actual
$0.20
EPS Est.
$0.22
EPS Surpr.
-8.8%
Revenue
$1.61B
Q3 FY2024
Aug 7, 2024Miss
EPS Actual
$0.08
EPS Est.
$0.09
EPS Surpr.
-13.9%
Revenue
$1.46B
Q2 FY2024
May 10, 2024Miss
EPS Actual
$0.04
EPS Est.
$0.11
EPS Surpr.
-60.8%
Revenue
$1.72B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $28.50 | $30.47 | $32.25 | 1 |
| Q4 FY2026 | $19.69 | $21.05 | $22.28 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $290B | $305B | $319B | 2 |
| Q4 FY2027 | $267B | $281B | $293B | 3 |
| Q3 FY2027 | $256B | $270B | $282B | 3 |
| Q2 FY2027 | $239B | $251B | $263B | 3 |
| Q1 FY2027 | $293B | $309B | $323B | 3 |
| Q4 FY2026 | $258B | $271B | $284B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +193.5% | $9.70 | $10.23 | +5.46% |
| ▼ Q1 FY2026 | Feb 13, 2026 | -44.2% | $12.30 | $12.30 | +0.00% |
| ▲ Q2 FY2025 | May 13, 2025 | +55.1% | $12.65 | $12.65 | +0.00% |
| ▼ Q1 FY2025 | Feb 14, 2025 | -31.2% | $13.03 | $13.03 | +0.00% |
| ▼ Q4 FY2024 | Nov 8, 2024 | -8.8% | $18.00 | $18.00 | +0.00% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -13.9% | $15.70 | $15.70 | +0.00% |
| ▼ Q2 FY2024 | May 10, 2024 | -60.8% | $14.60 | $15.34 | +5.07% |
| ▼ Q1 FY2024 | Feb 14, 2024 | -30.3% | $13.91 | $13.00 | -6.54% |
Q2 FY2026+5.46%
Report Date
May 12, 2026
EPS Beat/Miss
+193.5%
Price Before
$9.70
Price After
$10.23
Q1 FY2026+0.00%
Report Date
Feb 13, 2026
EPS Beat/Miss
-44.2%
Price Before
$12.30
Price After
$12.30
Q2 FY2025+0.00%
Report Date
May 13, 2025
EPS Beat/Miss
+55.1%
Price Before
$12.65
Price After
$12.65
Q1 FY2025+0.00%
Report Date
Feb 14, 2025
EPS Beat/Miss
-31.2%
Price Before
$13.03
Price After
$13.03
Q4 FY2024+0.00%
Report Date
Nov 8, 2024
EPS Beat/Miss
-8.8%
Price Before
$18.00
Price After
$18.00
Q3 FY2024+0.00%
Report Date
Aug 7, 2024
EPS Beat/Miss
-13.9%
Price Before
$15.70
Price After
$15.70
Q2 FY2024+5.07%
Report Date
May 10, 2024
EPS Beat/Miss
-60.8%
Price Before
$14.60
Price After
$15.34
Q1 FY2024-6.54%
Report Date
Feb 14, 2024
EPS Beat/Miss
-30.3%
Price Before
$13.91
Price After
$13.00
Avg Beat Reaction+2.73%
Avg Miss Reaction-0.24%
Beat Rate2 / 8 quarters
Largest Move-6.54% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OCPNF ends December
Olympus Corporation (OCPNF) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $0.14 — beating the analyst consensus of $0.05 by +193.5%. The next OCPNF earnings date is expected around September 1, 2026.
Each quarter, investors track OCPNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OCPNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OCPNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OCPNF earnings · 5 questionsOlympus Corporation's next earnings report is expected around September 1, 2026. OCPNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OCPNF historically reports after market close (AMC).
OCPNF earnings datewhen is OCPNF earningsOCPNF next earnings datewhen does OCPNF report earningsOCPNF earnings calendar
▸ Source: FMP · Olympus Corporation SEC filings · US GAAP · Olympus Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026